Abiopharma

New Form SCHEDULE 13G - BIOLIFE SOLUTIONS INC Filed: 2025-08-14 AccNo: 0001897612-25-000347 Size: 7 KB

New Form SCHEDULE 13G - Karyopharm Therapeutics Inc. Filed: 2025-08-14 AccNo: 0001897612-25-000365 Size: 9 KB

New Form NT 10-Q - Bespoke Extracts, Inc. Filed: 2025-08-14 AccNo: 0001213900-25-076307 Size: 17 KB

New Form SCHEDULE 13G/A - Tenaya Therapeutics, Inc. Filed: 2025-08-14 AccNo: 0000902664-25-003594 Size: 10 KB

Philips Announces Plan for More Than USD 150 Million of New Investment in Manufacturing and R&D in the U.S. to Expand Production of AI-powered Health Technology Innovations

New Form SCHEDULE 13G - Sagimet Biosciences Inc. Filed: 2025-08-14 AccNo: 0000902664-25-003593 Size: 8 KB

New Form SCHEDULE 13G - Tango Therapeutics, Inc. Filed: 2025-08-14 AccNo: 0000902664-25-003592 Size: 8 KB

New Form 4 - RETRACTABLE TECHNOLOGIES INC Filed: 2025-08-14 AccNo: 0001415889-25-021763 Size: 5 KB

New Form SCHEDULE 13G/A - Aligos Therapeutics, Inc. Filed: 2025-08-14 AccNo: 0000902664-25-003590 Size: 8 KB

Change - Announcement of Appointment: Appointment of Group Chief Financial Officer

Change - Announcement of Appointment :: Appointment of Group Chief Financial Officer

Change - Announcement of Cessation :: Cessation of Group Chief Financial Officer

Change - Announcement of Cessation: Cessation of Group Chief Financial Officer

Financial Statements and Related Announcement: Half Yearly Results

Financial Statements and Related Announcement :: Half Yearly Results